(Q24602988)
Statements
A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder (English)
Carlos A Zarate
David A Luckenbaugh
Nancy Brutsche
Lobna Ibrahim
W Joseph Herring
William Z Potter
1 reference
1 reference
1 reference
1 reference